Table 6 |
|||||
|
Bleeding and coagulation. |
|||||
|
HES 130/0.4(n = 100) |
NaCl 0.9%(n = 96) |
P value |
|||
|
|
|||||
|
Number of patients with RBC transfusions, n (%) |
29 (29.0) |
20 (20.8) |
0.2480 |
||
|
Volume (ml) of RBC transfusions, n (mean ± SD, range) |
100 (214 ± 358, 0 to 1,394) |
96 (165 ± 354, 0 to 1,661) |
0.3415 |
||
|
Blood loss, ml, including blood sampling and drainage, n (mean ± SD, range) |
63 (10.0 ± 24.4, 0.4 to 150.7) |
65 (10.5 ± 29.4, 0.2 to 207.8) |
NS |
||
|
|
|||||
|
Coagulation parameters, median values over time |
INR |
aPTT (ratio) |
INR |
aPTT (ratio) |
P value |
|
|
|||||
|
Baseline |
1.3 |
1.2 |
1.3 |
1.2 |
|
|
Until HDSa |
0.1 |
0.2 |
0.0 |
0.1 |
|
|
Day 1 |
0.0 |
0.1 |
0.0 |
0.1 |
|
|
Day 2 |
-0.1 |
0.1 |
-0.1 |
0.0 |
|
|
Day 3 |
-0.1 |
0.1 |
-0.2 |
0.0 |
|
|
Day 4 |
-0.2 |
0.1 |
-0.2 |
-0.1 |
|
|
Day 5 |
-0.1 |
0.0 |
-0.1 |
-0.1 |
|
|
Day 8b |
-0.1 |
0.0 |
-0.2 |
0.0 |
|
|
Lastc |
-0.1 |
0.0 |
-0.2 |
0.0 |
|
|
|
|||||
|
aFirst measurement until HDS visit (i.e., data recorded at day of withdrawal were assigned to the study visit corresponding to the actual time point of measurement); bdata recorded on Day 8; clast available post-baseline measurement; RBC, red blood cell; SD, standard deviation; HDS, hemodynamic stabilization; HES, hydroxyethyl starch; NaCI, sodium chloride. |
|||||
|
Guidet et al. Critical Care 2012 16:R94 doi:10.1186/cc11358 |
|||||
